International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released May 29, 2020, after the close
10-K filed Jun 1, 2020, 153 days after period end · 0001564590-20-027718
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.84M | $2.22M | $1.84M | $1.69M |
| Net Income | -$2.71M | -$1.03M |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$1.39M |
| $2.16M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
